It was further demonstrated that pharmacologic inhibition of SIRT1/2 caused a marked reduction in aromatase protein levels and SIRT1 immunohistochemistry showed a significant up-regulation in invasive ductal carcinoma relative to normal tissue adjacent to tumor. The gene discussed is CYP19A1; the disease is neoplasm.